Hydroxychloroquine did not stop Kovid-19 among health workers in new study

The study, which ended early, involved 125 health care workers – some of whom took hydroxychloroquine daily for eight weeks while others took placebo.

Based on their findings, researchers at the University of Pennsylvania wrote that they “cannot recommend the regular use of hydroxychloroquine among health care workers to prevent Kovid-19.”

Participants enrolled in the new study from April to July. It found that four out of 64 health workers who were randomly given hydroxychloroquine tested positive for Kovid-19 and four out of 61 health workers who were tested positive for placebo.

According to the study, of the eight participants who tested positive, six developed symptoms, none required hospitalization and all of them recovered from the disease.

Overall, the findings of the new research are similar to those reported in another study in the New England Journal of Medicine in June. That previous study found that Kovid-19 did not prevent hydroxychloroquine disease within four days of exposure to coronovirus.
READ: Trump's physician issues letter to president taking hydroxychloroquine
In June, an author of that previous study, Dr. David Boulware told CNN that the president’s physician sent him an email on May 9 asking for his opinion about stopping the drug, and asked about the results and dosage of the study. Were taking study subjects.

Boulware said he advised Trump’s physician that there had been no published research demonstrating hydroxychloroquine, worked preventively, and shared that those in his study who took hydroxychloroquine had higher rates of side effects Was, mostly gastrointestinal problems such as nausea and vomiting.

“I knew they were probably going to ignore my point because the White House had been talking about hydroxychloroquine for weeks and weeks and weeks,” said Boolware, an infectious disease specialist and professor of medicine at the University of Minnesota.

“Even in the setting of an epidemic, we need research to help inform best practice for what works in humans,” Bowlware said.

In July, the US Food and Drug Administration revoked an emergency use authority for hydroxychloroquine and chloroquine for the treatment of Kovid-19. The agency now states that hydroxychloroquine and chloroquine have not been shown to be safe and effective for the treatment or prevention of Kovid 19.

Leave a Reply

Your email address will not be published.